Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 5 IN PLASTIC CONTAINER versus OSMITROL 20 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 5 IN PLASTIC CONTAINER versus OSMITROL 20 IN WATER IN PLASTIC CONTAINER.
MANNITOL 5% IN PLASTIC CONTAINER vs OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases the osmolarity of the glomerular filtrate, reducing tubular reabsorption of water and solutes. It also draws water from intracellular spaces into the extracellular fluid, reducing cerebral edema and intraocular pressure.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal tubular osmotic pressure, thereby inhibiting water reabsorption and promoting diuresis.
50-100 g intravenously over 30-60 minutes for initial dose in acute renal failure or cerebral edema; maintenance dose 25-50 g every 6-8 hours based on serum osmolality and urine output.
0.25-1 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours if needed.
None Documented
None Documented
Terminal elimination half-life: 1–2 hours (adults with normal renal function); prolonged to 24–48 hours in severe renal impairment.
Terminal elimination half-life is 0.25–1.5 hours in normal renal function; prolonged to 4–6 hours with anuria or oliguria. Clinically, osmotic diuresis lasts as long as urine output sustains concentration.
Renal: >90% as unchanged drug via glomerular filtration; negligible biliary or fecal elimination.
Primarily renal (90-100% unchanged) via glomerular filtration; <3% metabolized in liver; minimal biliary/fecal excretion.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic